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IZUMO is the mouse sperm protein proven to be essential for fusion with eggs. It contains one immuno-
globulin-like domain with a conserved glycosylation site within. In the present paper, we produced trans-
genic mouse lines expressing unglycosylated IZUMO (N204Q-IZUMO) in Izumo1 !/! background. The
expression of N204Q-IZUMO rescued the infertile phenotype of IZUMO disrupted mice, indicating glyco-
sylation is not essential for fusion-facilitating activity of IZUMO. The N204Q-IZUMO was produced in tes-
tis in comparable amounts to wild-type IZUMO, but the amount of N204Q-IZUMO on sperm was
significantly decreased by the time sperm reached the cauda epididymis. These data suggest that glyco-
sylation is not essential for the function of IZUMO, but has a role in protecting it from fragmentation in
cauda epididymis.
! 2008 Elsevier Inc. All rights reserved.
Glycosylation is the most common post-translational modifi-
cation of proteins, with glycans involved in many key biological
processes such as cell adhesion, molecular trafficking and
clearance, receptor activation, signal transduction, and endocyto-
sis [1].
The importance of glycans has been demonstrated in reproduc-
tive biology. For example, when the enzyme a-mannosidase IIx
(MX) is disrupted, spermatogenic cells fail to adhere to Sertoli cells
and are prematurely released from the testis, resulting in male
infertility [2]. Disruption of the testis-specific, lectin-type molecu-
lar chaperone CALMEGIN leads to the disappearance of various gly-
coproteins from sperm surface and results in male infertility [3–5].
On the other hand, the importance of O-linked glycan of the
zona component ZP3, which forms a sperm receptor [6], has been
reported. This was reinforced by the experiment in which mouse
ZP3 gene was replaced by human gene. The result indicated that
the peptide sequence of ZP3 is not the crucial factor for species-
specific binding of sperm [7]. Moreover, it has been suggested for
many years that D(+)-glucosamine, bovine–albumin–glucosamide
and D(+)-galactosamide, fucoidan and dextran sulphate have inhib-
itory effects on sperm–egg fusion [8], but the mechanism of their
actions is not clarified.
Recently, we reported IZUMO null sperm cannot fuse with eggs
[9]. Since IZUMO is a member of an immunoglobulin superfamily
protein and possesses a well-conserved putative N-glycosylation
site, we examined the role of the glycosylation in IZUMO. For this
purpose, we produced transgenic mouse lines that have IZUMO
with no N-glycosylation site and crossed to the IZUMO disrupted
mouse line. The fertilizing ability of these mice with unglycosy-
lated IZUMO was analyzed both in vitro and in vivo to elucidate
the role of glycosylation in IZUMO.
Materials and methods
Animals, cells, and antibodies. IZUMO-null mice were prepared
as indicated in our previous paper [9]. BDF1 male and female mice
were purchased from SLC. Chinese hamster ovary (CHO) cells were
obtained from RIKEN Cell Bank (RIKEN, Saitama, Japan). Anti-IZU-
MO monoclonal antibody (#125) was previously generated in our
laboratory according to the standard method [3]. All of the exper-
iments were performed with the approval of the Animal Care and
Use Committee of Osaka University.
Western blotting. Proteins from testis, corpus epididymis and
epididymal sperm were solubilized with 1% Triton X-100,
150 mM NaCl, 50 mM Tris–HCl (pH 8.0) and 1% protease inhibitor
cocktail (nakalai tesque, Kyoto, Japan), and was centrifuged at
15,000 rpm for 30 min at 4 "C. The supernatants were denatured
by boiling for 5 min in the presence of 1% SDS with or without
6% 2-mercaptoethanol, separated by SDS–PAGE, and transferred
onto Immobilon-P membranes (Millipore, MA, USA). After blocking
with 10% skimmed milk, the blots were incubated with primary
antibodies for 2 h and then incubated with horseradish peroxi-
dase-conjugated secondary antibodies for 1 h. Immunoreactive
proteins were detected by an ECL Western blotting detection kit
(GE Healthcare, Little Chalfont, England).
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Deglycosylation assay of IZUMO. The methods for analyses using
deglycosidase were described previously [10]. Briefly, sperm were
solubilized with solubilization buffer containing 1% Triton X-100,
20 mM Tris-maleate (pH 7.4), 1 mM PMSF for N-glycosidase F, or
1% Triton X-100, 20 mM sodium citrate (pH 5.9), 1 mM PMSF for
Endglycosidase H, or 1% Triton X-100, 20 mM Tris–maleate (pH
6.0), 1 mM PMSF for O-glycosidase. Solubilized proteins were cen-
trifuged at 15,000 rpm for 30 min at 4 "C and the supernatants
were treated with 250 mU of N-glycosidase, or 250 mU of Endgly-
cosidase, or 1 mU of O-glycosidase for 16 h at 37 "C. The samples
were subjected to SDS–PAGE followed by Western blotting. IZUMO
protein was detected with IZUMO polyclonal antibody.
Production of transgenic mice. A construct was prepared in the
pBluescript SK II+ plasmid. We designed testis-specific expression
construct inserting Izumo1 cDNA between Calmegin promoter and a
rabbit b-globin polyadenylation signal. Point mutation (N204Q) was
inserted using the QuikChange site-directed mutagenesis system
(Stratagene, CA,USA). All constructswere verifiedbyDNA sequencing
using an ABI 310 sequencer (Applied Biosystems, CA, USA).
Transgenic mouse lines were produced by injecting 2.3 kb AseI–
XhoI DNA fragment into pronuclei of BDF1 " BDF1 fertilized eggs.
Offspring carrying the transgene were identified by PCR using Pri-
mer A (50-CCTTCCTGCGGCTTGTTCTCT-30) and Primer B (50-GG
TCTCAGAACTTTGCTCCCAAACCCTGTA-30) for wild-type Izumo1
and N204Q-Izumo1 cDNA. The endogenous Izumo1 and their mu-
tated alleles were detected by PCR using Primer C (50-GGGTT
CACTCTCCAGCTACCCCAAACTCAC-30) and Primer D (50-CAGAAC
CCCGAACCCAGCCTATGCC-30), and Primer E (50-GCTTGCCGAATATC
ATGGTGGAAAATGGCC-30) and Primer D, respectively.
Sperm–egg fusion assay.Mouse sperm were collected from cau-
da epididymides and capacitated in vitro for 2 h in 200 ll drop of
TYH medium covered with paraffin oil. Female mice (>8-weeks-
old) were superovulated with injection of 5 IU of hCG (human
chorionic gonadotropin) 48 h after a 5 IU injection of equine cho-
rionic gonadotropin (eCG). The eggs were collected from the ovi-
duct 14 h after the hCG injection. Eggs were placed in a 200 ll
drop of TYH medium. After being freed from cumulus cells with
0.01% (w/v) hyaluronidase, the zona pellucida was removed from
mouse eggs using a piezo-manipulator as previously reported
[11]. The zona-free mouse oocytes were pre-loaded with Hoechst
33342 by incubating them with 1 lg/ml of the dye in TYH for
10 min. After washing, the eggs were incubated with
2 " 105 sperm/ml incubated for 30 min at 37 "C in 5% CO2, and
unbound sperm were washed away. The eggs were observed un-
der a fluorescence microscope (UV excitation light) after fixing
with 0.25% glutaraldehyde. This procedure enabled staining of
only fused sperm nucleus by transferring the dye into sperm
after membrane fusion as in Fig. 2C.
Observation of zona pellucida-penetrated sperm. B6D2F1 females
were superovulated by intraperitoneal injection of 5 IU of eCG, fol-
lowed 48 h later by 5 IU of hCG. Superovulated females were caged
together with test males after hCG injection, and the formation of
vaginal plug was observed 20 h later. Eggs were collected from the
oviduct and placed in a 200 ll drop of TYH medium. After being
freed from cumulus cells with 0.01% (w/v) hyaluronidase, these
eggs were washed several times by transferring them into fresh
medium. Immunostaining was performed by incubating the fertil-
ized eggs with 1 lg/ml #125 Mab for 1 h at 37 "C in 5% CO2 in
100 ll TYH medium and subsequently secondary antibody staining
was done with 10 lg/ml Alexa fluor 546-conjugated anti-rat IgG
(Invitrogen, CA, USA) in 100 ll drop of TYH medium for 1 h at
37 "C in 5% CO2. After repeated washing to observe zona pellu-
cida-penetrated sperm, four small dabs of Vaserine mix (Vaseline:
solid paraffin = 9:1) were applied on a slide glass. The eggs were
gently pressed with cover glass to flatten them under the stereo-
scopic microscope, and were then viewed using a fluorescence
microscope.
Results
Glycosylation status in IZUMO
IZUMO has four putative O-glycosylation sites at the 268th,
274th, 279th and 282nd threonine according to computer analysis
using NetOGlyc 3.1 Server (http://www.cbs.dtu.dk/services/NetO-
Glyc/). However, when we treated IZUMO with O-glycosidase, we
couldnot observe anydecrease inmolecularweight, suggesting IZU-
MOdoesnot have anyO-glycans (Fig. 1B). Since IZUMOwasalso pre-
dicted topossess awell-conservedN-glycosylationsite in themiddle
of an immunoglobulin-like loop among species (Fig. 1A), we treated
mouse sperm IZUMO with two kinds of N-glycosidases and exam-
ined the change of molecular weight. The molecular weight of Endo
human      167 ERNV-E--VPQMEDMILDCELNWHQASEGLTDYSFYRVWGNNTETLVSKGKEATLTKPMVGPEDAGSYRCELGSVNSSPATIINFHVTVL 253
chimpanzee 167 ERNV-E--VPQMEDMILDCELNWHQASEGLTDYSFYRVWGNNTETLVSKGKEATLTKPMVGPEDAGSYRCELGSVNSSPATIINFHVTVL 253
macaca     167 ERNV-E--VPQMEDMILDCELNWHQASEGLTDYSFYRVWGNNTETLVSKGKEPTLTKSMVGPEDAGSYRCELGSVNSSPATVINFRVTVL 253
dog        165 ---VHEVVVHELEDLVLDCELSWHRISAGLNNYTFYRVLGSNSLLLSV-GKEPTLTKTMVRLEDAGTYRCELANMKTSRAAVTHFRVRVL 250
opossum    214 EQAVQV-IEKG—-DLILDCELSWHKKAEGLTTYSFFKILTNGTEVLLSRGKDSALTKPMVAFEDGGSYRCILDTIRKHSPATIIVY---- 296
rat        167 ERQI-E--VHRLEDMVLDCQLSWHHASEGLTDYSFYRVWGNSSETLMSKGKEPYLTKTMVGPEDAGNYRCELDTVNAGPATIIYYHVTVL 253
mouse      167 ERHI-E--VHRSEDLVLDCLLSWHRASKGLTDYSFYRVWENSSETLIAKGKEPYLTKSMVGPEDAGNYRCVLDTINQGHATVIRYDVTVL 253
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Fig. 1. Deglycosylation study and establishment of N204Q-IZUMO mice. (A) Amino acid sequences of Immunoglobulin-like domain of IZUMO from human, chimpanzee,
macaca, dog, opossum, rat, and mouse. A N-glycoside link motif and putative cysteine residues that form a disulphide bridge are shown in red and blue, respectively. The
similar and identical amino acid residues are shown by a dot and asterisk, respectively. (B) Deglycosylation study of IZUMO. Solubilized sperm proteins (10 lg) were treated
with End H or N- or O-glycosidase. The samples were subjected to SDS–PAGE followed by Western blotting and detected with anti-IZUMO polyclonal antibody under non-
reduced conditions. (C) The constructs of transgene to express mouse N204Q-IZUMO were under the control of a Calmegin promoter. The locations of a pair of primers (A and
B) to clarify the transgene were indicated by arrows. (D) Identification of N204Q-IZUMO-expressing male mice. The upper panel shows 671-bp PCR band using Primer set A
and B. The lower panel shows Western blot analysis of testes extracts (50 lg) from transgenic mice. Western blot analysis under reduced conditions was performed by
detecting with anti-His tag antibody (Qiagen). The testes extracts from wild-type IZUMO rescue and wild-type were used as a positive and negative control, respectively.
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H-treated IZUMO was not altered, but N-glycosidase F-treated IZU-
MO showed higher electrophoretic mobility and the estimated
molecular weight changed from approximately 56–50 kDa
(Fig. 1B). Since Endo H N-glycosidase is reported to hydrolyze only
high mannose and some hybrid N-glycans, whereas N-glycosidase
F is reported to cleavemost N-glycans, including high mannose, hy-
brid, and complex structures, the digestion results indicate that IZU-
MO had a complex N-glycan structure. Since the stoichiometric
molecular mass of IZUMO deduced from its amino acid sequence is
43.5 k, there remains an additional possibility that IZUMO has been
modified by some means other than glycosylation, such as phos-
phorylation or palmitoylation etc.
Establishment of mutated IZUMO expressing mouse line under IZUMO-
null background (N204Q-IZUMO)
Since glycan composition is known to be involved in many
molecular interaction mechanisms [1], we tried to examine the
role of N-glycan on IZUMO. Accordingly we produced mouse
lines expressing mutated IZUMO by replacing 204th putative
N-glycosylation site (Asn-X-[Thr/Ser]) aspargine to glutamine
by site-directed mutagenesis, and inserted between a testis-spe-
cific Calmegin promoter and rabbit b-globin polyadenylation sig-
nal [4] (Fig. 1C). Since our previous studies showed the addition
of His-tag to the carboxy terminal of IZUMO did not affect its
function, we performed the above task to make the transgenic
protein distinguishable from endogenous IZUMO. After microin-
jection of the transgene into fertilized eggs and transplantation
into pseudopregnant female, we obtained 68 pups and among
those, 12 mice were shown to have the transgene by PCR
(Fig. 1D; upper panel). Transgenic mouse lines obtained were
tested for their expression of mutated IZUMO by Western blot
analysis. As illustrated in Fig. 1D, in 4 out of tested 5 transgenic
lines, we could detect the production of mutated #50 kDa IZU-
MO by anti-His tag antibody. The apparent expression levels of
IZUMO in testes of lines #4 and #5 were greater than those of
the His-tagged wild-type Izumo1 transgene that was already
shown to rescue the sterility of IZUMO-null male mice [9]
(Fig. 1D; lower panel). In the present experiment, lines #4 and
#5 were backcrossed to IZUMO-null mice to produce mutant
mouse lines that completely lack N-glycan of IZUMO (referred
to hereafter as N204Q-IZUMO).
The localization of transgenic N204Q-IZUMO and the fertility in male
mice
We established N204Q-IZUMO males of #4 and #5 transgenic
mouse lines with Izumo1!/! background to evaluate the necessity
of N-glycosylation in IZUMO. Three males from each of the trans-
genic mouse lines were each caged with three wild-type females
and kept for 3 months. Although the litter sizes were smaller com-
pared to the rescued Izumo1 !/! mice with wild-type IZUMO, the
N204Q-IZUMO of both #4 and #5 lines could rescue the infertile
sperm back to a fertile state (Fig. 2A). We then performed sperm–
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Fig. 2. Fusing ability and subcellular localization of N204Q-IZUMO. (A) Litter size of male mice of control wild-type, and IZUMO-null rescued by wild-type and N204Q-IZUMO
(#4, #5 lines) as a transgene. The numbers in parentheses indicate the numbers of mating pairs. Values are presented as means ± standard error of mean (SEM). (B and C)
Comparison of the fusing ability of wild-type and N204Q-IZUMO-rescued sperm. Average numbers of fused sperm observed 30 min after insemination (n = 4). Values are
presented as means ± SEM. Representative photos were shown in C. The arrowheads and asterisks indicate fused sperm and metaphase II-arrested chromosomes,
respectively. (D) The localization of N204Q-IZUMO after zona pellucida penetration in naturally acrosome reacted sperm. The migration of N204Q-IZUMO on zona penetrated
sperm (acrosome reacted sperm) was normal and seen in the entire head region as observed in wild-type sperm (red signal).
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egg fusion assay using zona-free eggs prepared by the piezo-manip-
ulator method [11]. The sperm from both #4 and #5 lines were able
to bind to the plasmamembrane of eggs as well as to wild-type IZU-
MO-rescued sperm when observed 30 min after the sperm insemi-
nation. The efficiency was low, but sperm from N204Q-IZUMO
could fuse with eggs (Fig. 2B and C).
IZUMO is located inside acrosome and exposed on sperm
surface only after acrosome reaction. After IZUMO is exposed
on the surface, it migrates and spreads across the entire head
area including the equatorial segment where sperm–egg fusion
takes place [9]. We then examined whether the loss of glycosyl-
ation in IZUMO affects the nature of translocation of IZUMO
after acrosome reaction. When we stained sperm inside the per-
ivitelline space, N204Q-IZUMO was found to be localized on en-
tire sperm head in the same manner with wild-type IZUMO
(Fig. 2D). These data suggest that the absence of N-glycan on
IZUMO had little or no influence on the transposition of the
antigen on sperm surface which accompanied acrosome reac-
tion. However, the staining intensities were dimmer than those
of wild-type IZUMO.
Putative function of N-glycan in IZUMO
We previously produced monoclonal antibody (Mab) against
mouse IZUMO (#125) [3]. We extracted proteins from testis and
sperm from male mice in lines #4 and #5 and analyzed them by
Western blot analysis using Mab#125. The N204Q-IZUMO was mi-
grated as a 50 kDa band probably due to the lack of N-linked glycan
at N204 site. However, in sperm, a severe fragmentation of N204Q-
IZUMO was observed while it was not apparent in wild-type IZU-
MO or testicular N204Q-IZUMO (Fig. 3A). The major fragmented
bands were observed at #30 and 35 kDa area. This fragmentation
was not observed in sperm until sperm reached the cauda epidid-
ymis (Fig. 3B). It should be noted that the 30 kDa band disappeared
when anti-His tag antibody was used, indicating that 35 kDa frag-
ment contains carboxy-terminal His tag, but that the 30 kDa band
did not (Fig. 3C).
Although N204Q-IZUMO could rescue the infertile phenotype,
the amount of intact N204Q-IZUMO presented on sperm was sig-
nificantly small compared to wild-type IZUMO in spite of an abun-
dance of N204Q-IZUMO in testis (Fig. 3A). This decrease was
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Fig. 3. Fragmentation of N204Q-IZUMO protein in cauda epididymal sperm. (A) N204Q-IZUMO is fragmented by protease in cauda epididymal sperm. Solubilized proteins
(30 lg) from testes and sperm were separated by SDS–PAGE in a 10% polyacrylamide gel, and detected with #125 Mab. Immunoglobulin superfamily protein BASIGIN
(CD147) was shown in the lower panel as a control. The arrow and filled and unfilled arrowheads are indicated by 50 kDa unglycosylated IZUMO and #30 and 35 kDa
fragmented products, respectively. (B) IZUMO reactivity in testis and epididymis. The 30 lg of proteins from extracts of testis (testicular cell), corpus epididymis (tissue) and
sperm from cauda epididymis were separated on a 10% SDS–PAGE and subjected to Western blot analysis. The bolts were incubated with #125 Mab. (C) Western blotting
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characteristic to N204Q-IZUMO and was not observed in the wild-
type IZUMO-rescued mice (Fig. 3A and C).
Discussion
Fragmentation of unglycosylated IZUMO in cauda epididymis
The membranous proteins of sperm are exposed to proteases,
and are modified during epididymal transit. For example, testicular
angiotensin I-converting enzyme (tACE) is released from the testic-
ular sperm membrane to epididymal fluid when sperm enter the
epididymis [12] and this is indispensable for sperm to bind to zona
pellucida properly [13].
IZUMO is a membrane protein and is not exposed to the
outside of sperm, but is hidden under the plasma membrane
before acrosome reaction. Therefore, the fragmentation of
unglycosylated IZUMO during epididymal maturation must be
caused by acrosomal proteases such as ACROSIN, TESP1, TESP2,
PRSS2 and PRSS21, etc. [14–17]. We reported the rise of pH le-
vel inside acrosome during the incubation of epididymal sperm
in capacitation medium [18]. This pH change could facilitate
some enzymes to be activated, but the enzyme that cleaves
IZUMO must be activated before capacitation. As far as we
know, there are no precedent papers reporting activation of
proteases inside acrosome during epididymal maturation.
Although the processing of unglycosylated IZUMO is not a phys-
iological phenomenon, the result indicates that some acrosomal
enzymes are activated during maturation in epididymis and
process membrane proteins. As of today, disruptions of a few
acrosomal enzymes are reported, but defects in sperm fertilizing
ability is not reported in vivo [15,19]. However, as indicated in
the present paper, active protease(s) exist inside acrosome. This
suggests that a processing of some membrane proteins during
epididymal maturation is essential for fertilization.
Subcellular localization and function of unglycosylated IZUMO
In virus, if the fusion (F) proteins are unglycosylated by
mutation, it is reported to be transported to the cell surface
and consequently not able to mediate cell–cell fusion [20,21].
However, unglycosylated IZUMO was transported to its proper
location and spread to the entire head surface after acrosome
reaction as in the normal IZUMO, indicating the glycosylation
of IZUMO is not essential for proper protein trafficking in
sperm.
It was clear that N204Q-IZUMO could rescue the sterile male to
fertile without the aid of glycosylation of IZUMO (Fig. 1A). This
indicates that the glycosylation is not ‘‘essential” for fusion. How-
ever, the N204Q-IZUMO rescue was not as effective as wild-type
IZUMO rescue. We think there are three possible explanations for
the inefficient rescue: (i) the lack of glycosylation decreased the fu-
sion-facilitating ability of IZUMO, (ii) the disappearance of glycan
in IZUMO evoked the fragmentation system and only a small
amount of IZUMO was retained on sperm, (iii) a mixture of (i)
and (ii).
Numerous glycoproteins have been proven to be involved in
sperm–egg interaction. [6,10]. However, the role of their glycan
moiety remains unclear. Using the gene disruption and its rescue
by mutant proteins, we could demonstrate that at least one of
the roles of N-glycan in IZUMO is to protect IZUMO from fragmen-
tation during sperm maturation in epididymis. As far as we
searched, this is the first in vivo indication of glycans proteolytic
fragmentation protecting activity.
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